hrcak mascot   Srce   HID

Izvorni znanstveni članak

A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY

Didem Toker
Hakan Tozan
Ozalp Vayvay

Puni tekst: engleski, pdf (2 MB) str. 101-114 preuzimanja: 362* citiraj
APA 6th Edition
Toker, D., Tozan, H. i Vayvay, O. (2013). A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY. Economic research - Ekonomska istraživanja, 26 (1), 101-114. Preuzeto s https://hrcak.srce.hr/104011
MLA 8th Edition
Toker, Didem, et al. "A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY." Economic research - Ekonomska istraživanja, vol. 26, br. 1, 2013, str. 101-114. https://hrcak.srce.hr/104011. Citirano 26.02.2020.
Chicago 17th Edition
Toker, Didem, Hakan Tozan i Ozalp Vayvay. "A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY." Economic research - Ekonomska istraživanja 26, br. 1 (2013): 101-114. https://hrcak.srce.hr/104011
Harvard
Toker, D., Tozan, H., i Vayvay, O. (2013). 'A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY', Economic research - Ekonomska istraživanja, 26(1), str. 101-114. Preuzeto s: https://hrcak.srce.hr/104011 (Datum pristupa: 26.02.2020.)
Vancouver
Toker D, Tozan H, Vayvay O. A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY. Economic research - Ekonomska istraživanja [Internet]. 2013 [pristupljeno 26.02.2020.];26(1):101-114. Dostupno na: https://hrcak.srce.hr/104011
IEEE
D. Toker, H. Tozan i O. Vayvay, "A DECISION MODEL FOR PHARMACEUTICAL MARKETING AND A CASE STUDY IN TURKEY", Economic research - Ekonomska istraživanja, vol.26, br. 1, str. 101-114, 2013. [Online]. Dostupno na: https://hrcak.srce.hr/104011. [Citirano: 26.02.2020.]

Sažetak
The choice of the appropriate product for the portfolio of a pharmaceutical company in terms of its strategy and long term commercial value is a sophisticated multi-criteria decision problem in pharma economics. This paper provides a systematic method for licensing in pharma industry and proposes a Fuzzy AHP based decision model for the decision makers in pharmaceutical industry to assess potentials of different products for license-in that may be proper for their portfolio. An application of the proposed model is also performed for a pharmaceutical company in Turkey.

Ključne riječi
Marketing; Decision making; Pharma industry

Hrčak ID: 104011

URI
https://hrcak.srce.hr/104011

[hrvatski]

Posjeta: 734 *